Biotage Dirección
Dirección controles de criterios 3/4
El CEO de Biotage's es Torben Jorgensen, nombrado en Jan 2024, tiene una permanencia de menos de un año. posee directamente un 0.4% de las acciones de la empresa, con un valor de SEK54.75M. La antigüedad media del equipo directivo y de la junta directiva es de 3.4 años y 2.5 años, respectivamente.
Información clave
Torben Jorgensen
Chief Executive Officer (CEO)
SEK 857.0k
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | less than a year |
Participación del CEO | 0.4% |
Permanencia media de la dirección | 3.5yrs |
Promedio de permanencia en la Junta Directiva | 2.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Are Investors Undervaluing Biotage AB (publ) (STO:BIOT) By 39%?
Jun 08Is Biotage AB (publ) (STO:BIOT) Potentially Undervalued?
May 21Revenue Beat: Biotage AB (publ) Exceeded Revenue Forecasts By 5.3% And Analysts Are Updating Their Estimates
Apr 28Biotage's (STO:BIOT) Dividend Will Be SEK1.60
Apr 17Biotage AB (publ) Just Beat EPS By 53%: Here's What Analysts Think Will Happen Next
Apr 08Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Apr 03Biotage (STO:BIOT) Has Announced A Dividend Of SEK1.60
Mar 04Weak Statutory Earnings May Not Tell The Whole Story For Biotage (STO:BIOT)
Feb 22Subdued Growth No Barrier To Biotage AB (publ) (STO:BIOT) With Shares Advancing 32%
Feb 21Biotage AB (publ) Just Recorded A 53% EPS Beat: Here's What Analysts Are Forecasting Next
Feb 18Biotage (STO:BIOT) Has A Pretty Healthy Balance Sheet
Feb 08Investors Still Waiting For A Pull Back In Biotage AB (publ) (STO:BIOT)
Jan 07At kr124, Is It Time To Put Biotage AB (publ) (STO:BIOT) On Your Watch List?
Dec 08Estimating The Intrinsic Value Of Biotage AB (publ) (STO:BIOT)
Oct 27Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Jul 12An Intrinsic Calculation For Biotage AB (publ) (STO:BIOT) Suggests It's 26% Undervalued
Jun 08Biotage (STO:BIOT) Ticks All The Boxes When It Comes To Earnings Growth
May 24Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 05These 4 Measures Indicate That Biotage (STO:BIOT) Is Using Debt Safely
Mar 12Is It Too Late To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 21Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06Biotage (STO:BIOT) Seems To Use Debt Rather Sparingly
Dec 03Is Now The Time To Look At Buying Biotage AB (publ) (STO:BIOT)?
Oct 27Estimating The Fair Value Of Biotage AB (publ) (STO:BIOT)
Oct 07Biotage (STO:BIOT) Could Easily Take On More Debt
Sep 03Is There Now An Opportunity In Biotage AB (publ) (STO:BIOT)?
Jul 10A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jun 25Do Biotage's (STO:BIOT) Earnings Warrant Your Attention?
May 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Apr 23Biotage (STO:BIOT) Is Paying Out A Larger Dividend Than Last Year
Mar 29Does Biotage (STO:BIOT) Have A Healthy Balance Sheet?
Mar 14Is It Time To Consider Buying Biotage AB (publ) (STO:BIOT)?
Feb 28Biotage's (STO:BIOT) Upcoming Dividend Will Be Larger Than Last Year's
Feb 13A Look At The Fair Value Of Biotage AB (publ) (STO:BIOT)
Jan 23Is Biotage (STO:BIOT) A Risky Investment?
Dec 10Is Now The Time To Put Biotage (STO:BIOT) On Your Watchlist?
Nov 03Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Mar 31 2024 | n/a | n/a | SEK 236m |
Dec 31 2023 | SEK 857k | n/a | SEK 246m |
Sep 30 2023 | n/a | n/a | SEK 189m |
Jun 30 2023 | n/a | n/a | SEK 216m |
Mar 31 2023 | n/a | n/a | SEK 240m |
Dec 31 2022 | SEK 817k | n/a | SEK 268m |
Sep 30 2022 | n/a | n/a | SEK 240m |
Jun 30 2022 | n/a | n/a | SEK 228m |
Mar 31 2022 | n/a | n/a | SEK 216m |
Dec 31 2021 | SEK 732k | n/a | SEK 205m |
Sep 30 2021 | n/a | n/a | SEK 203m |
Jun 30 2021 | n/a | n/a | SEK 187m |
Mar 31 2021 | n/a | n/a | SEK 174m |
Dec 31 2020 | SEK 2m | SEK 1m | SEK 175m |
Sep 30 2020 | n/a | n/a | SEK 149m |
Jun 30 2020 | n/a | n/a | SEK 179m |
Mar 31 2020 | n/a | n/a | SEK 201m |
Dec 31 2019 | SEK 7m | SEK 3m | SEK 187m |
Sep 30 2019 | n/a | n/a | SEK 196m |
Jun 30 2019 | n/a | n/a | SEK 173m |
Mar 31 2019 | n/a | n/a | SEK 170m |
Dec 31 2018 | SEK 7m | SEK 3m | SEK 168m |
Sep 30 2018 | n/a | n/a | SEK 175m |
Jun 30 2018 | n/a | n/a | SEK 162m |
Mar 31 2018 | n/a | n/a | SEK 148m |
Dec 31 2017 | SEK 6m | SEK 3m | SEK 139m |
Compensación vs. Mercado: La compensación total de Torben($USD82.13K) está por debajo de la media de empresas de tamaño similar en el mercado Swedish ($USD772.87K).
Compensación vs. Ingresos: La compensación de Torben ha sido consistente con los resultados de la empresa en el último año.
CEO
Torben Jorgensen (72 yo)
less than a year
Permanencia
SEK 857,000
Compensación
Mr. Torben Jorgensen, B.Sc. serves as President at Biotage AB form January 04, 2024 and serves as its as CEO since 2024 and served as its as Interim CEO since January 04, 2024 until 2024 and served as its...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO, President & Director | less than a year | SEK 857.00k | 0.40% SEK 53.8m | |
Chief Financial Officer | less than a year | sin datos | sin datos | |
Executive Vice President of Operations | 14.2yrs | sin datos | 0.0064% SEK 864.3k | |
EVP of Global Marketing | no data | sin datos | sin datos | |
Chief Human Resources & Sustainability Officer | no data | sin datos | 0.019% SEK 2.5m | |
President of Americas & Chief/Head of Americas | no data | sin datos | 0.0064% SEK 864.3k | |
Chief Auditor | no data | sin datos | sin datos | |
Executive Vice President of Business Development | no data | sin datos | 0.025% SEK 3.4m | |
President of International - EMEA and APAC | 4.1yrs | sin datos | 0.0064% SEK 864.3k | |
Executive Vice President of IT & Digitalization | no data | sin datos | 0.0059% SEK 787.7k | |
Executive Vice President of Quality Assurance & Regulatory Affairs | 3.5yrs | sin datos | sin datos | |
Executive Vice President R&D | no data | sin datos | sin datos |
3.5yrs
Permanencia media
52.5yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de BIOT se considera experimentado (3.4 años antigüedad media).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO, President & Director | 4.7yrs | SEK 857.00k | 0.40% SEK 53.8m | |
Chairman | 1.3yrs | SEK 227.00k | sin datos | |
Director | 11.3yrs | SEK 407.00k | 0.020% SEK 2.7m | |
Director | 4.7yrs | SEK 337.00k | sin datos | |
Director | 5.3yrs | SEK 307.00k | sin datos | |
Director | 1.3yrs | sin datos | sin datos | |
Employee Representative Director | 2.6yrs | sin datos | sin datos | |
Director | 2.3yrs | SEK 357.00k | sin datos | |
Employee Representative Director | no data | sin datos | sin datos | |
Employee Representative Director | less than a year | sin datos | sin datos |
2.6yrs
Permanencia media
61.5yo
Promedio de edad
Junta con experiencia: La junta directiva de BIOT no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.